GABAergic system gene expression predicts clinical outcome in patients with neuroblastoma

Journal of Clinical Oncology

Volumn 22, Issue 20, 2004, Pages 4127-4134

  Roberts, Stephen S ^a   Mori, Motomi ^a   Pattee, Patrick ^a   Lapidas, Jodi ^a   Matthews, Ravi ^a   O'Malley, Jean P ^a   Hsieh, Yi Ching ^a   Turner, Mark A ^a   Wang, Zhaohong ^a   Tian, Qi ^a   Rodland, Matthew J ^a   Reynolds, C Patrick ^a   Seeger, Robert C ^a   Nagalla, Srinivasa R ^a  

^a CHILDREN S ONCOLOGY GROUP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; MESSENGER RNA; TUMOR MARKER; GABARAP PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ARTICLE; CONTROLLED STUDY; GABAERGIC SYSTEM; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPPRESSION SUBTRACTIVE HYBRIDIZATION; GENETICS; INFANT; MULTIVARIATE ANALYSIS; NUCLEIC ACID HYBRIDIZATION; SURVIVAL RATE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; GENE EXPRESSION; HUMANS; INFANT; MICROTUBULE-ASSOCIATED PROTEINS; MULTIVARIATE ANALYSIS; NEUROBLASTOMA; NUCLEIC ACID HYBRIDIZATION; PROGNOSIS; RECEPTORS, GABA-A; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 7044229712     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.02.032     Document Type: Article

References (47)

1. Gurney JG, Severson RK, Davis S, et al: Incidence of cancer in children in the United States: Sex-, race-, and 1-year age-specific rates by histologic type. Cancer 75:2186-2195, 1995
2. Maris JM, Brodeur GM: Neuroblastoma, in Pizzo PA, Poplack DG (eds): Principles and Practice of Pediatric Oncology (ed 4). Philadelphia, PA, Lippincott Williams & Wilkins, 2001, pp 895-937
3. Matthay KK, Villabianca JG, Seeger RC, et al: Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid: Children's Cancer Group. N Engl J Med 341:1165-1173, 1999
4. Haas D, Ablin AR, Miller C, et al: Complete pathologic maturation and regression of stage IVS neuroblastoma without treatment. Cancer 62:818-825, 1988
5. Brodeur GM, Maris JM, Yamashiro DJ, et al: Biology and genetics of human neuroblastomas. J Pediatr Hematol Oncol 19:93-101, 1997
6. Brodeur GM, Seeger RC, Schwab M, et al: Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224:1121-1124, 1984
7. Seeger RC, Brodeur GM, Sather H, et al: Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313:1111-1116, 1985
8. White PS, Thompson PM, Seifried BA, et al: Detailed molecular analysis of 1p36 in neuroblastoma. Med Pediatr Oncol 36:37-41, 2001
9. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, et al: Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 328:847-854, 1993
10. Brodeur GM, Nakagawara A, Yamashiro DJ, et al: Expression of TrkA, TrkB and TrkC in human neuroblastomas. J Neurooncol 31:49-55, 1997
11. Choi L, Kim N, Zuo JJ, et al: Telomerase activity by TRAP assay and telomerase RNA (hTR) expression are predictive of outcome in neuroblastoma. Med Pediatr Oncol 35:647-650, 2000
12. Tedder TF, Streuli M, Schlossman SF, et al: Isolation and structure of a cDNA encoding the B1 (CD20) cell-surface antigen of human B lymphocytes. Proc Natl Acad Sci U S A 85:208-212, 1988
13. Hubank M, Schatz DG: Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res 22:5640-5648, 1994
14. Schummer M, Ng W, Nelson PS, et al: Inexpensive handheld device for the construction of high-density nucleic acid arrays. Biotechniques 23:1087-1092, 1997
15. Velculescu VE, Zhang L, Vogelstein B, et al: Serial analysis of gene expression. Science 270:484-487, 1995
16. Diatchenko L, Lau YF, Campbell AP, et al: Suppression subtractive hybridization: A method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci U S A 93:6025-6030, 1996
17. Glisin V, Crkvenjakov R, Byus C: Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry 13:2633, 1974
18. Seidman JG: Screening of recombinant DNA libraries, in Ausubel FM, Brent R, Kingston RE, et al (eds): Current Protocols in Molecular Biology, Vol 1. Hoboken, NJ, John Wiley & Sons, 1996, pp 6.1-6.12.12
19. Evans AE, D'Angio GJ, Randolph J: A proposed staging for children with neuroblastoma: Children's Cancer Study Group A. Cancer 27:374-378, 1971
20. Johnson MR, Wang K, Smith JB, et al: Quantitation of dihydropyrimidine dehydrogenase expression by real-time reverse transcription polymerase chain reaction. Anal Biochem 278:175-184, 2000
21. Shimada H, Ambros IM, Dehner LP, et al: The International Neuroblastoma Pathology Classification (the Shimada system). Cancer 86:364-372, 1999
22. Rosner B: Foundation of Biostatistics (ed 5). Pacific Grove, CA, Duxbury, 2000
23. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-460, 1958
24. Cox DR: Regression models and life tables. J R Stat Soc 34:187-220, 1972
25. Dombroski BA, Scott AF, Kazazian HH Jr: Two additional potential retrotransposons isolated from a human L1 subfamily that contains an active retrotransposable element. Proc Natl Acad Sci U S A 90:6513-6517, 1993
26. Bratthauer GL, Cardiff RD, Fanning TG: Expression of LINE-1 retrotransposons in human breast cancer. Cancer 73:2333-2336, 1994
27. Bratthauer GL, Fanning TG: LINE-1 retrotransposon expression in pediatric germ cell tumors. Cancer 71:2383-2386, 1993
28. Nickerson HJ, Matthay KK, Seeger RC, et al: Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: A Children's Cancer Group study. J Clin Oncol 18:477-486, 2000
29. Owens DF, Kriegstein AR: Is there more to GABA than synaptic inhibition? Nat Rev Neurosci 3:715-727, 2002
30. Waagepetersen HS, Sonnewald U, Schousboe A: The GABA paradox: Multiple roles as metabolite, neurotransmitter, and neurodifferentiative agent. J Neurochem 73:1335-1342, 1999
31. Schofield PR, Darlison MG, Fujita N, et al: Sequence and functional expression of the GABA A receptor shows a ligand-gated receptor super-family. Nature 328:221-227, 1987
32. Nayeem N, Green TP, Martin IL, et al: Quaternary structure of the native GABAA receptor determined by electron microscopic image analysis. J Neurochem 62:815-818, 1994
33. Macdonald RL, Olsen RW: GABAA receptor channels. Annu Rev Neurosci 17:569-602, 1994
34. McKernan RM, Whiting PJ: Which GABAA-receptor subtypes really occur in the brain? Trends Neurosci 19:139-143, 1996
35. Wang H, Bedford FK, Brandon NJ, et al: GABA(A)-receptor-associated protein links GABA(A) receptors and the cytoskeleton. Nature 397:69-72, 1999
36. Coyle JE, Qamar S, Rajashankar KR, et al: Structure of GABARAP in two conformations: Implications for GABA(A) receptor localization and tubulin binding. Neuron 33:63-74, 2002
37. Chen L, Wang H, Vicini S, et al: The gamma-aminobutyric acid type A (GABAA) receptor-associated protein (GABARAP) promotes GABAA receptor clustering and modulates the channel kinetics. Proc Natl Acad Sci U S A, 97:11557-11562, 2000
38. Antonopoulos J, Pappas IS, Parnavelas JG: Activation of the GABAA receptor inhibits the proliferative effects of bFGF in cortical progenitor cells. Eur J Neurosci 9:291-298, 1997
39. Cameron HA, Hazel TG, McKay RD: Regulation of neurogenesis by growth factors and neurotransmitters. J Neurobiol 36:287-306, 1998
40. Wolff JR, Joo F, Dames W: Plasticity in dendrites shown by continuous GABA administration in superior cervical ganglion of adult rat. Nature 274:72-74, 1978
41. Berninger B, Marty S, Zafra F, et al: GABAergic stimulation switches from enhancing to repressing BDNF expression in rat hippocampal neurons during maturation in vitro. Development 121:2327-2335, 1995
42. Ganguly K, Schinder AF, Wong ST, et al: GABA itself promotes the developmental switch of neuronal GABAergic responses from excitation to inhibition. Cell 105:521-532, 2001
43. Fritschy JM, Paysan J, Enna A, et al: Switch in the expression of rat GABAA-receptor subtypes during postnatal development: An immunohistochemical study. J Neurosci 14:5302-5324, 1994
44. Behar TN, Schaffner AE, Tran HT, et al: GABA-induced motility of spinal neuroblasts develops along a ventrodorsal gradient and can be mimicked by agonists of GABAA and GABAB receptors. J Neurosci Res 42:97-108, 1995
45. Azuma H, Inamoto T, Sakamoto T, et al: Gamma-aminobutyric acid as a promoting factor of cancer metastasis: Induction of matrix metalloproteinase production is potentially its underlying mechanism. Cancer Res 63:8090-8096, 2003
46. Maris JM, Guo C, Blake D, et al: Comprehensive analysis of chromosome 1p deletions in neuroblastoma. Med Pediatr Oncol 36:32-36, 2001
47. Emberger W, Windpassinger C, Petek E, et al: Assignment of the human GABAA receptor delta-subunit gene (GABRD) to chromosome band 1p36.3 distal to marker NIB1364 by radiation hybrid mapping. Cytogenet Cell Genet 89:281-282, 2000